January 11, 2018
Novartis appoints new Oncology CEO
Novartis has appointed Elizabeth Barrett, currently Global President Oncology at Pfizer, Inc., as the CEO Novartis Oncology and a member…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Novartis
January 4, 2018
Breaktrhough Terapy in USA for Novartis’s Promacta, blood disorder treatment
Novartis could soon offer SAA patients new treatment, as it on Thursday announced getting the Breakthrough Therapy for its Promacta…
January 3, 2018
Trends in OTC pharma packaging
While physically over-the-counter (OTC) medicine packaging may mirror the prescription drug market, with continued strong demand for plastic primary pharmaceutical…
January 3, 2018
Second breakthrough therapy mark for Novartis’s Kisqali
Novartis on Wednesday sadi that Kisqali has gotten US Food and Drug Administration (FDA) Breakthrough Therapy designation for initial endocrine-based…
November 30, 2017
Novartis’ Cosentyx shows efficacy in nail and palmoplantar psoriasis
Novartis has announced first-of-its-kind long-term data showing that Cosentyx (secukinumab) provided sustained improvements in nail and palmoplantar psoriasis out to…
November 20, 2017
EC approves Novartis’s Tasigna
The European Commission (EC) has approved Novartis’s Tasigna for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic…
November 14, 2017
Novartis to present new data about broad range of breast cancer
Novartis announced it would present data across its breast cancer portfolio and pipeline in a broad range of patient populations,…
November 8, 2017
Positive results from Novartis’s third phase testing of Kisqali in breast cancer
Novartis on Wednesday announced positive topline results from the global MONALEESA-7 trial, the second Phase III trial of Kisqali in…
November 6, 2017
Novartis submits MAA to EMA for CTL019 for 2 indications. Also says Cosetnyx performs well for ankylosing spondylitis patients
Novartis on Monday said that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for…
November 3, 2017
Novartis, Amgen, Banner Alzheimer’s to see if investigational drug can prevent Alzheimer’s symptoms
Novartis, Amgen and the Banner Alzheimer’s Institute (BAI) on Thursday revealed expanding collaboration to initiate a new trial on the…